Arctic Wolf Recognized on the 2024 Fortune Future 50 List for its Sustained and Continued Business Growth
Cybersecurity leader’s growth powered by demand for the Arctic Wolf Aurora™ Platform…
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
November 18, 2024 11:15 ET | Source: BridgeBio Pharma, Inc. - Acoramidis…